Back Other Health News Drug Use and Harm Reduction

Other Infections

HR17: Combining Drug Addiction Treatment and Perinatal HIV Prevention Leads to Good Outcomes

An integrated program offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.

alt

Read more:

HR17: Indonesian Buyers Club Helps People Obtain Generic Hepatitis C Treatment

A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral drugs to treat hepatitis C and is seeing a high cure rate, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.

alt

Read more:

HR17: Hydromorphone Works as Well as Heroin-Assisted Drug Addiction Treatment

Hydromorphone was as effective as pharmaceutical heroin for opioid addiction treatment, but it was associated with fewer serious side effects, according to results from the SALOME trial presented at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

PAS 2017: New Approaches Help Babies with Opioid Withdrawal Syndrome

Letting mothers and babies room together and using methadone or buprenorphine instead of morphine to manage withdrawal symptoms leads to shorter stays and other benefits for newborns with neonatal abstinence syndrome (NAS), according to several presentations at the Pediatric Academic Societies Meeting this month in San Francisco.

alt

Read more:

HR17: AA Amyloidosis Is an Unrecognized Problem Among People Who Inject Drugs

AA amyloidosis, a condition resulting from skin and soft tissue infections that can lead to kidney failure, may be more common than previously recognized among people who inject drugs, according to a presentation at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

HR17: Overamping Is a Common Problem Among People Who Use Stimulants

Overdosing on stimulants such as methamphetamine -- known as "overamping" -- is an under-recognized problem in a harm reduction community that more often focuses on opioid overdose, according to a presentation at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

10. Not Enough Syringe Programs for People Who Inject Drugs

The opioid epidemic in the U.S. -- with its attendant risk of overdose and HIV and viral hepatitis transmission -- remained a concern in 2016, with new data showing that many people who inject drugs do not have consistent access to sterile syringes.

alt

Read more:

HR17: Drug Checking Reveals High Levels of Fentanyl Contamination

A pilot project to check the purity of drugs at Vancouver's Insite safe injection facility found that around 80% of tested samples contained fentanyl, and people who learned their drugs were contaminated were more likely to reduce their doses and less likely to overdose, researchers reported at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

27 Million People in U.S. Use Illicit Drugs, Harm Reduction Not Keeping Pace

Nearly 21 million people in the United States struggle with substance use disorders, according to a new report, Facing Addiction in America: Surgeon General's Report on Alcohol, Drugs, and Health, released this week. Another new report by Harm Reduction International finds that harm reduction services are not adequate in the U.S. or worldwide, though the U.S. has seen some recent improvements.

alt

Read more: